NO20055582L - Compositions and Methods comprising Gastrin Compounds - Google Patents

Compositions and Methods comprising Gastrin Compounds

Info

Publication number
NO20055582L
NO20055582L NO20055582A NO20055582A NO20055582L NO 20055582 L NO20055582 L NO 20055582L NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 L NO20055582 L NO 20055582L
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
beneficial effects
gastrin
Prior art date
Application number
NO20055582A
Other languages
Norwegian (no)
Other versions
NO20055582D0 (en
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/en
Publication of NO20055582L publication Critical patent/NO20055582L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

Oppfinnelsen vedrører generelt nye sammensetninger og fremgangsmåter omfattende en gastrinforbindelse. Sammensetningene og fremgangsmåtene tilveiebringer fordelaktige effekter, særlig vedvarende fordelaktige effekter, i behandlingen av diabetes.The invention generally relates to novel compositions and methods comprising a gastrin compound. The compositions and methods provide beneficial effects, particularly sustained beneficial effects, in the treatment of diabetes.

NO20055582A 2003-05-27 2005-11-25 Compositions and Methods comprising Gastrin Compounds NO20055582L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 NO20055582D0 (en) 2005-11-25
NO20055582L true NO20055582L (en) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (en) 2003-05-27 2005-11-25 Compositions and Methods comprising Gastrin Compounds

Country Status (11)

Country Link
EP (1) EP1648495A2 (en)
JP (1) JP2007513059A (en)
CN (1) CN1829528A (en)
AU (1) AU2004243541A1 (en)
BR (1) BRPI0410710A (en)
CA (1) CA2527186A1 (en)
MX (1) MXPA05012605A (en)
NO (1) NO20055582L (en)
PL (1) PL379145A1 (en)
RU (1) RU2005140518A (en)
WO (1) WO2004105780A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1351742B1 (en) 2001-01-12 2008-10-15 Waratah Pharmaceuticals Inc. Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
US7560425B2 (en) 2002-06-07 2009-07-14 Waratah Pharmaceuticals Inc. Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes
RU2006131046A (en) * 2004-01-30 2008-03-10 Уэрейта Фармасьютикалз, Инк. (Ca) JOINT USE OF GLP-1 AGONIST AND GASTRIN COMPOUNDS
US20100256061A1 (en) * 2007-03-02 2010-10-07 Antonio Cruz Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
EP1132091A1 (en) * 1994-01-24 2001-09-12 The General Hospital Corporation Treatment for diabetes
EP1351742B1 (en) * 2001-01-12 2008-10-15 Waratah Pharmaceuticals Inc. Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands
JP2006506386A (en) * 2002-10-22 2006-02-23 ワラタ ファーマシューティカルズ， インコーポレイテッド Diabetes treatment

Also Published As

Publication number Publication date
MXPA05012605A (en) 2006-02-22
CA2527186A1 (en) 2004-12-09
NO20055582D0 (en) 2005-11-25
RU2005140518A (en) 2007-07-10
JP2007513059A (en) 2007-05-24
WO2004105780A3 (en) 2005-01-20
CN1829528A (en) 2006-09-06
EP1648495A2 (en) 2006-04-26
PL379145A1 (en) 2006-07-24
WO2004105780A2 (en) 2004-12-09
AU2004243541A1 (en) 2004-12-09
BRPI0410710A (en) 2006-06-13

Similar Documents

Publication Publication Date Title
NO20091976L (en) New connections
IS7721A (en) Piperidine-pyridazone and thalasone which inhibit PDE4
MX2007005933A (en) Acetamide compounds as fungicides.
HK1079519A1 (en) Furyl compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
IS2696B (en) Substituted 2-aminotetraline for the treatment of depression
MX2007005408A (en) Aminoquinazolines compounds.
HRP20080564T3 (en) Dihydrotetrabenazines and pharmaceutical compositions containing them
IN2012DN02609A (en)
NO20070608L (en) Use of 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines in the treatment of nausea and vomiting
EA200700096A1 (en) DERIVATIVES 2-CARBAMID-4-PHENYL THIAZOLE, METHOD FOR THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
MX2007005932A (en) 1-alkynyl-2-aryloxyalkylamides and their use as fungicides.
MX2007002470A (en) Substituted phenylaminothiazoles and use thereof.
TW200600499A (en) Novel amido-substituted hydroxy-6-phenylphenanthridines
DE60333746D1 (en) thienyl compounds
HK1096549A1 (en) Imidazopyridine-derivatives as inducible no-synthase inhibitors
MXPA05011962A (en) Substituted oxyarenes, and use thereof for controlling pests.
TW200621703A (en) Alkylidene-tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
ATE549024T1 (en) QUINAZOLINE POTASSIUM CHANNEL INHIBITORS
NO20055582L (en) Compositions and Methods comprising Gastrin Compounds
ATE359283T1 (en) SUBSTITUTED PYRAZINONE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION
RS20060206A (en) Aminopyridine-derivatives as inducible no-synthase inhibitors
DE602004018811D1 (en) PYRROLIDINE HYDROGEN DERIVATIVES AS ANGIOGENESE INHIBITORS
MXPA06000372A (en) Silicon compounds and their use.
NO20053562L (en) Novel aminobenzophenone compounds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application